In order to meet the domestic and global demand of coronavirus vaccines, and to prepare for any future pandemic threats, the U.S. Government announced plans to spend billions of dollars to expand vaccine manufacturing capacity.
With the goal of producing at least one billion additional doses a year starting by the second half of 2022, the Biden administration is offering financial support to pharmaceutical companies that have experience in manufacturing mRNA vaccines, including Pfizer Inc. and Moderna Inc.
For comments and feedback contact: editorial@rttnews.com
Political News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.